12.1
消化管 (GI) 診断検査は、がんを含むさまざまな疾患の確認、除外、診断、またはステージングに極めて重要です。診断後、患者との話し合いの時間を設け、情報源を提供することが重要です。消化管の診断評価は、内視鏡室や GI 検査室などの外来診療所で行われることがよくあります。これらの検査の準備には、食事制…
胃腸検査には、血清、呼気、便の検査が含まれます。
まず、肝機能検査などの血清研究は、肝障害の特定に役立ちます。アミラーゼとリパーゼのレベルの上昇は、多くの場合、膵臓の炎症を示しています。包括的な代謝パネルは、腎臓と肝臓の機能、電解質バランス、血糖値を評価します。
さらに、癌胎児性抗原などの腫瘍マーカーは結腸直腸癌を検出し、癌抗原19-9は膵臓癌を検出します。
次に、水素呼気検査のような呼気検査では、特に乳糖不耐症や小腸細菌の異常増殖における炭水化物の吸収不良が特定されます。
尿素呼気検査では、消化性潰瘍疾患に関連する細菌であるピロリ菌が検出されます。
最後に、便検査は、便の一貫性、色、膿、粘液、寄生虫、潜血を調べることにより、診断情報を提供します。
糞便培養は、サルモネラ菌などの細菌を特定し、下痢や食中毒の診断に役立ちます。
最後に、グアヤックベースの便潜血検査と便免疫化学検査は、結腸直腸がんのスクリーニングの鍵です。
View the full transcript and gain access to JoVE Core videos
Q1: What do liver function tests reveal about gastrointestinal health?
Liver function tests assess liver health by measuring liver enzymes, proteins, and bilirubin levels in the blood. Abnormal results may indicate liver disorders such as hepatitis or cirrhosis. These serum studies help identify hepatic dysfunction and guide treatment decisions for patients with suspected liver disease.
Q2: How do elevated amylase and lipase levels indicate pancreatic problems?
Elevated amylase and lipase levels often indicate pancreatic inflammation, particularly pancreatitis. These enzymes are released into the bloodstream when pancreatic tissue is damaged or inflamed. While increased levels suggest pancreatitis, they may also rise in other conditions, making clinical correlation essential for accurate diagnosis.
Q3: What is the difference between the hydrogen breath test and urea breath test?
The hydrogen breath test identifies carbohydrate malabsorption, such as lactose intolerance and small intestinal bacterial overgrowth, by measuring hydrogen levels in exhaled breath. The urea breath test detects Helicobacter pylori, a bacterium associated with peptic ulcer disease. Both are non-invasive diagnostic methods targeting different gastrointestinal conditions.
Q4: How do tumor markers like CEA and CA 19-9 help detect gastrointestinal cancers?
Carcinoembryonic antigen detects colorectal carcinoma, while cancer antigen 19-9 detects pancreatic cancer. Elevated levels may suggest the presence of cancer, though they can also occur in other conditions. These tumor markers are valuable screening and monitoring tools but are not diagnostic on their own and must be used alongside imaging studies and clinical evaluation.
Q5: What information does stool examination provide about gastrointestinal disorders?
Stool tests examine consistency, color, pus, mucus, parasites, and occult blood to diagnose gastrointestinal conditions. Stool culture identifies bacteria such as Salmonella, aiding in diagnosing diarrhea and food poisoning. These observations can indicate bleeding, infections, infestations, or malabsorption syndromes affecting the digestive system.
Q6: Why are fecal occult blood tests important for colorectal cancer screening?
Guaiac-based fecal occult blood testing and fecal immunochemical tests are key screening tools for colorectal cancer. Hidden blood in stool is a crucial marker for conditions like colorectal cancer. The fecal immunochemical test offers higher specificity for human hemoglobin and is preferred for colorectal cancer screening over guaiac-based tests.
Q7: What does the comprehensive metabolic panel evaluate in gastrointestinal assessment?
The comprehensive metabolic panel evaluates kidney and liver function, electrolyte balance, and blood sugar levels. This broad overview of body chemistry is essential for diagnosing metabolic disorders and understanding overall organ function. It provides critical information for assessing patients with gastrointestinal complaints and systemic involvement.